• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据肝脏硬度状态分析HIV/HCV合并感染患者的免疫系统失调情况

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.

作者信息

Garcia-Broncano Pilar, Medrano Luz Maria, Berenguer Juan, González-García Juan, Jiménez-Sousa Mª Ángeles, Carrero Ana, Hontañón Victor, Guardiola Josep M, Crespo Manuel, Quereda Carmen, Sanz José, García-Gómez Ana Belen, Jimenez Jose Luis, Resino Salvador

机构信息

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

Viral Infection and Immunity Unit, National Center of Microbiology, Health Institute Carlos III, 28220 Madrid, Spain.

出版信息

Cells. 2018 Nov 2;7(11):196. doi: 10.3390/cells7110196.

DOI:10.3390/cells7110196
PMID:30400258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6262386/
Abstract

BACKGROUND

Advanced cirrhosis is related to alterations in immunity. We aimed to evaluate the levels of peripheral CD4⁺ T cells (Tregs) and plasma cytokine in patients coinfected with human immunodeficiency virus and hepatitis C virus (HIV/HCV) according to liver fibrosis stages [evaluated as liver stiffness measure (LSM)] and their linear relationship.

METHODS

We performed a cross-sectional study on 238 HIV/HCV-coinfected patients (119 had <12.5 kPa, 73 had 12.5⁻25 kPa, and 46 had >25 kPa). Peripheral T-cell subsets were phenotyped by flow cytometry, plasma biomarkers were assessed by multiplex immunoassays, and LSM was assessed by transient elastography. Results We found HIV/HCV-coinfected patients had higher values of CD4⁺ Tregs ( < 0.001), memory Tregs ( ≤ 0.001), and plasma cytokine levels [IFN-γ ( ≤ 0.05) and IL-10 ( ≤ 0.01)] compared with healthy donors and HIV-monoinfected patients. In the multivariate analysis, higher LSM values were associated with reduced levels of IL-10 (adjusted arithmetic mean ratio (aAMR) = 0.83; = 0.019), IL-2 (aAMR = 0.78; = 0.017), TNF-α (aAMR = 0.67; < 0.001), and IL-17A (aAMR = 0.75; = 0.006). When we focus on HIV/HCV-coinfected patients analyzed by LSM strata, patients with ≥25 kPa had lower values of IL-2 (aAMR = 0.66; = 0.021), TNF-α (aAMR = 0.565; = 0.003), and IL-17A (aAMR = 0.58; = 0.003) than patients with <12.5 kPa.

CONCLUSION

HIV/HCV-coinfected patients showed an immunosuppressive profile compared to healthy controls and HIV-monoinfected patients. Additionally, HIV/HCV-coinfected patients with advanced cirrhosis (LSM ≥ 25 kPa) had the lowest plasma values of cytokines related to Th1 (IL-2 and TNF-α) and Th17 (IL-17A) response.

摘要

背景

晚期肝硬化与免疫功能改变有关。我们旨在根据肝纤维化分期[以肝脏硬度值(LSM)评估]及其线性关系,评估人类免疫缺陷病毒和丙型肝炎病毒合并感染(HIV/HCV)患者外周血CD4⁺调节性T细胞(Tregs)水平和血浆细胞因子水平。

方法

我们对238例HIV/HCV合并感染患者进行了一项横断面研究(119例LSM<12.5 kPa,73例LSM为12.5⁻25 kPa,46例LSM>25 kPa)。通过流式细胞术对外周血T细胞亚群进行表型分析,通过多重免疫测定评估血浆生物标志物,通过瞬时弹性成像评估LSM。结果我们发现,与健康供体和HIV单感染患者相比,HIV/HCV合并感染患者的CD4⁺Tregs(<0.001)、记忆性Tregs(≤0.001)和血浆细胞因子水平[IFN-γ(≤0.05)和IL-10(≤0.01)]更高。在多变量分析中,较高的LSM值与IL-10水平降低相关(校正算术平均比[aAMR]=0.83;P=0.019)、IL-2(aAMR=0.78;P=0.017)、TNF-α(aAMR=0.67;P<0.001)和IL-17A(aAMR=0.75;P=0.006)。当我们关注按LSM分层分析的HIV/HCV合并感染患者时,LSM≥25 kPa的患者与LSM<12.5 kPa的患者相比,IL-2(aAMR=0.66;P=

相似文献

1
Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.根据肝脏硬度状态分析HIV/HCV合并感染患者的免疫系统失调情况
Cells. 2018 Nov 2;7(11):196. doi: 10.3390/cells7110196.
2
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.肝硬度升高与 HIV/丙型肝炎病毒合并感染患者的炎症和免疫激活生物标志物升高有关。
AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787.
3
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.在短期内,人类免疫缺陷病毒/丙型肝炎病毒合并感染且纤维化程度较轻的患者发生肝失代偿的风险较低。
Hepatology. 2015 May;61(5):1503-11. doi: 10.1002/hep.27674. Epub 2015 Mar 20.
4
Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.肝脏硬度和天冬氨酸转氨酶水平可预测丙型肝炎病毒/艾滋病病毒合并感染患者肝纤维化进展的风险。
HIV Med. 2015 Apr;16(4):211-8. doi: 10.1111/hiv.12197. Epub 2014 Sep 18.
5
Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.HIV/丙型肝炎病毒合并感染且伴有晚期纤维化的个体发生肝失代偿的风险:对治疗时机的影响。
Clin Infect Dis. 2013 Nov;57(10):1401-8. doi: 10.1093/cid/cit537. Epub 2013 Aug 14.
6
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.在丙型肝炎单感染及人类免疫缺陷病毒/丙型肝炎合并感染患者中使用实时剪切波弹性成像评估肝纤维化
J Ultrasound Med. 2016 Jun;35(6):1299-308. doi: 10.7863/ultra.15.08066. Epub 2016 May 5.
7
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.无论有无肝纤维化及是否合并HIV感染,活跃的丙型肝炎病毒(HCV)感染均与循环中干扰素-γ(IFN-γ)诱导蛋白10(IP-10)、可溶性CD163及炎性单核细胞水平升高有关。
Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):644-655. doi: 10.1016/j.clinre.2017.04.007. Epub 2017 May 31.
8
Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals.使用直接抗病毒药物根除丙型肝炎病毒后,HIV/丙型肝炎病毒合并感染的肝硬化患者端粒长度增加
J Clin Med. 2020 Jul 28;9(8):2407. doi: 10.3390/jcm9082407.
9
PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study.HIV/HCV合并感染患者中具有临床显著门静脉高压高风险的晚期肝硬化的外周血单个核细胞基因表达特征:一项交叉对照研究。
Biomed Pharmacother. 2023 Mar;159:114220. doi: 10.1016/j.biopha.2023.114220. Epub 2023 Jan 9.
10
PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study.PPARγ2 Pro12Ala多态性与HIV/HCV合并感染患者良好的心脏代谢风险特征相关:一项横断面研究。
J Transl Med. 2014 Aug 27;12:235. doi: 10.1186/s12967-014-0235-9.

引用本文的文献

1
Recent advances in poor HIV immune reconstitution: what will the future look like?HIV免疫重建不良的最新进展:未来会怎样?
Front Microbiol. 2023 Aug 7;14:1236460. doi: 10.3389/fmicb.2023.1236460. eCollection 2023.
2
Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study.微囊化脐带华通氏胶来源的成人间充质干细胞作为COVID-19疾病患者潜在的新型治疗工具:一项体外研究。
Am J Stem Cells. 2021 Aug 15;10(3):36-52. eCollection 2021.
3
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.

本文引用的文献

1
Liquid biopsy for liver diseases.液体活检在肝脏疾病中的应用。
Gut. 2018 Dec;67(12):2204-2212. doi: 10.1136/gutjnl-2017-315846. Epub 2018 Sep 3.
2
Liquid biopsy: still early days for early detection.液体活检:早期检测仍处于起步阶段。
Lancet. 2018 Jun 30;391(10140):2593-2594. doi: 10.1016/S0140-6736(18)31476-4.
3
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.肝硬度升高与 HIV/丙型肝炎病毒合并感染患者的炎症和免疫激活生物标志物升高有关。
两种病毒的故事:HCV/HIV 合并感染的免疫学见解。
Front Immunol. 2021 Aug 12;12:726419. doi: 10.3389/fimmu.2021.726419. eCollection 2021.
4
Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.血浆炎症生物标志物与 HIV/HCV 共感染个体的晚期肝纤维化相关。
Int J Environ Res Public Health. 2020 Dec 17;17(24):9474. doi: 10.3390/ijerph17249474.
5
Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.慢性丙型肝炎病毒感染的炎症和心血管疾病生物标志物:综述。
Clin Cardiol. 2020 Mar;43(3):222-234. doi: 10.1002/clc.23299. Epub 2019 Nov 30.
6
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression.人类免疫缺陷病毒和嗜肝病毒合并感染作为肝损伤进展的诱导因素。
World J Gastroenterol. 2019 Jan 28;25(4):398-410. doi: 10.3748/wjg.v25.i4.398.
AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787.
4
Role of inflammatory response in liver diseases: Therapeutic strategies.炎症反应在肝脏疾病中的作用:治疗策略。
World J Hepatol. 2018 Jan 27;10(1):1-7. doi: 10.4254/wjh.v10.i1.1.
5
The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders.转化生长因子β-1在HIV/AIDS进展及非艾滋病定义性纤维化疾病发展中的作用
Front Immunol. 2017 Nov 2;8:1461. doi: 10.3389/fimmu.2017.01461. eCollection 2017.
6
IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation.HIV感染会抑制Th17细胞中的IL-23信号传导,且高效抗逆转录病毒治疗无法恢复该信号传导:对持续性免疫激活的影响。
PLoS One. 2017 Nov 1;12(11):e0186823. doi: 10.1371/journal.pone.0186823. eCollection 2017.
7
Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.免疫与纤维化形成:Th17/白细胞介素-17轴在乙肝病毒和丙肝病毒诱导的慢性肝炎及向肝硬化进展中的作用
Front Immunol. 2017 Sep 28;8:1195. doi: 10.3389/fimmu.2017.01195. eCollection 2017.
8
Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma.慢性乙型肝炎、丙型肝炎和肝细胞癌患者的血清细胞因子谱差异。
Sci Rep. 2017 Sep 19;7(1):11867. doi: 10.1038/s41598-017-11975-7.
9
CD4+ T cells from HIV-1 patients with impaired Th1 effector responses to Mycobacterium tuberculosis exhibit diminished histone and nucleoprotein signatures.对结核分枝杆菌的Th1效应反应受损的HIV-1患者的CD4 + T细胞表现出组蛋白和核蛋白特征的减少。
Clin Immunol. 2017 Aug;181:16-23. doi: 10.1016/j.clim.2017.05.018. Epub 2017 May 25.
10
IL-10: A Multifunctional Cytokine in Viral Infections.白细胞介素-10:病毒感染中的多功能细胞因子。
J Immunol Res. 2017;2017:6104054. doi: 10.1155/2017/6104054. Epub 2017 Feb 20.